Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

C

COAG

Hemab Therapeutics Holdings Inc

41.19

Sep 18 • 3:59 PM ET -0.03 (-0.07%)

41.19

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Peers: LABT VBIO ABVC ACET AARD AAPG ABEO ABOS ABCL SRXH

| Held by: VTI VXF SCHA TMSL SCHB VTWO FHLC MSSM WSML VTWG

Scroll to Statements

Index	-
Market Cap	1.92B
Enterprise Value	1.47B
Income	-
Sales	-
Book/sh	9.73
Cash/sh	9.79
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	72
IPO	May 01, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	4.23
P/C	4.21
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	35.85
Current Ratio	35.85
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.54
EPS next Q	-0.51
EPS this Y	95.41%
EPS next Y	18.15%
EPS next 5Y	63.77%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-9.22% -

Insider Own	38.27%
Insider Trans	19.93%
Inst Own	64.62%
Inst Trans	46.39%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-6.87%
SMA50	-11.73%
SMA200	9.15%
Trades

Shs Outstand	46.71M
Shs Float	28.84M
Short Float	7.31%
Short Ratio	5.47
Short Interest	2.11M
52W High	55.42 -25.68%
52W Low	23.00 79.09%
Volatility	7.08% 7.97%
ATR (14)	3.28
RSI (14)	40.17
Beta	-
Rel Volume	10.77
Avg Volume	385.39K
Volume	4,149,107

Perf Week	4.54%
Perf Month	-20.27%
Perf Quarter	40.87%
Perf Half Y	-
Perf YTD	52.56%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	61.20
Prev Close	41.22
Price	41.19
Change %	-0.07%

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)